Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 02, 2016 16:54 ET | Source: MediWound Ltd.

MediWound’s EscharEx® Meets Primary Endpoint in Second Phase 2 Clinical Trial for the Debridement of Chronic and Hard-to-Heal Wounds

Data demonstrate strong results in diabetic foot ulcers and venous leg ulcers Conference call with MediWound management and key opinion leader begins February 3, 2016 at 8:30 a.m. Eastern time ...
January 25, 2016 07:00 ET | Source: MediWound Ltd.

MediWound Reports 2015 Fourth Quarter and Full Year Financial Results

YAVNE, Israel, Jan. 25, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
January 21, 2016 08:00 ET | Source: MediWound Ltd.

MediWound Expands Latin American Distribution of NexoBrid Through Agreement With Avalon Pharmaceutical S.A

YAVNE, Israel, Jan. 21, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
January 19, 2016 08:00 ET | Source: MediWound Ltd.

MediWound to Host Fourth Quarter and Year End 2015 Financial Results Conference Call on January 25, 2016 at 8:30 a.m. Eastern Time

YAVNE, Israel, Jan. 19, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated, biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
January 11, 2016 08:30 ET | Source: MediWound Ltd.

MediWound’s NexoBrid Highlighted in Presentations at the 4th International Conference on Healthcare System Preparedness and Response to Emergencies and Disasters

YAVNE, Israel, Jan. 11, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
December 23, 2015 07:00 ET | Source: MediWound Ltd.

MediWound Appoints Aharon Yaari as Chairman of Its Board of Directors

YAVNE, Israel, Dec. 23, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe...
December 01, 2015 09:45 ET | Source: MediWound Ltd.

MediWound to Present at the Oppenheimer 26th Annual Healthcare Conference

YAVNE, Israel, Dec. 1, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...
December 01, 2015 07:00 ET | Source: MediWound Ltd.

MediWound Appoints Aharon Yaari to Its Board of Directors

YAVNE, Israel, Dec. 1, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...
November 12, 2015 08:30 ET | Source: MediWound Ltd.

MediWound to Present at the Canaccord Genuity 2015 Medical Technology & Diagnostics Forum

YAVNE, Israel, Nov. 12, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...
November 06, 2015 08:00 ET | Source: MediWound Ltd.

MediWound to Present at the Credit Suisse 24th Annual Healthcare Conference

YAVNE, Israel, Nov. 6, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...